Formation of large oligomers of DOPAL-modified α-synuclein is modulated by the oxidation of methionine residues located at C-terminal domain
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 509 (2) , 367-372
Abstract
No abstract availableKeywords
Funding Information
- Medical College, Weill Cornell Medicine
- Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico
This publication has 24 references indexed in Scilit:
- Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified α-synucleinBiochemical and Biophysical Research Communications, 2018
- Superoxide is the critical driver of DOPAL autoxidation, lysyl adduct formation, and crosslinking of α-synucleinBiochemical and Biophysical Research Communications, 2017
- Toxic Dopamine Metabolite DOPAL Forms an Unexpected Dicatechol Pyrrole Adduct with Lysines of α‐SynucleinAngewandte Chemie International Edition, 2016
- Dopamine quinones interact with α-synuclein to form unstructured adductsBiochemical and Biophysical Research Communications, 2010
- Formation of dopamine-mediated α-synuclein-soluble oligomers requires methionine oxidationFree Radical Biology and Medicine, 2009
- Extrinsic Fluorescent Dyes as Tools for Protein CharacterizationPharmaceutical Research, 2008
- Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamineActa Neuropathologica, 2007
- α‐Synuclein facilitates the toxicity of oxidized catechol metabolites: Implications for selective neurodegeneration in Parkinson's diseaseFEBS Letters, 2006
- Methionine oxidation, α-synuclein and Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2005
- 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson’s disease pathogenesisBrain Research, 2003